[Usefulness of ranitidine in the treatment of esophagitis caused by gastro-esophageal acid reflux].
The results of a randomised prospective study conducted on 40 patients with erosive oesophagitis caused by gastro-oesophageal acid reflux are reported. The patients were divided into two groups and given either ranitidine or a placebo. The clinical and endoscopic evolution confirmed by the histological findings and pH figures demonstrated a significantly better performance in the patients treated with ranitidine. No clinically significant side effects were noted.
Nervi
M
M
Conte
M
M
Buttitta
F
F
Spisni
R
R
D000328:Adult; D000368:Aged; D004942:Esophagitis, Peptic / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D011899:Ranitidine / Q000627:therapeutic use*; D012074:Remission Induction
D011899:Ranitidine
Utilità della ranitidina nella terapia dell'esofagite da reflusso acido gastro-esofageo.